Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,579,245
-$875,575 QoQ
Shares Held
190,168
-2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#631
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. PFE ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
This page
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,579,245 | 190,168 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,454,820 | 194,260 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,794,793 | 192,562 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $4,640,239 | 182,113 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,512,712 | 186,168 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $4,313,146 | 170,211 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,347,046 | 163,854 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,570,689 | 192,491 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,449,524 | 194,765 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,119,987 | 148,468 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,272,234 | 148,393 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,443,827 | 164,119 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,847,012 | 159,406 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,246,847 | 153,109 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,379,482 | 144,018 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,061,241 | 138,511 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $6,902,933 | 131,660 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $7,430,379 | 125,832 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,280,079 | 122,764 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,425,510 | 113,011 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,510,329 | 152,093 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $5,077,166 | 137,929 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,916,657 | 133,969 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,322,584 | 132,189 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,132,022 | 126,594 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||